{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:33:07Z","timestamp":1792978387247,"version":"4.5.0"},"reference-count":221,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Neuroendocrinology"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This paper includes a summary of the main points of our recent presentation at the 2025 RegPep meeting in Washington, DC. In the invitation to make this presentation by the meeting organizers, we were asked to include a discussion of peptide directed imaging and theranostics to areas that would be of interest to the attendees, which primarily includes studies related to the CNS. The interest in the possible application of peptide theranostics to oncology both generally and in the case of the CNS tumors has markedly increased over the last few years because of its successful application in both neuroendocrine tumors and prostate cancer, leading to FDA approved novel tumor approaches for both imaging these tumors as well as for its theranostic approach. In this paper we review the scientific basis for the successful application of peptide theranostics to neuroendocrine and prostate cancer, and the current status of its application to CNS tumors, particularly meningiomas, glioblastomas including glioblastoma multiforme, and medulloblastomas. We particularly concentrate on the possible use of the somatostatin, bombesin (Bn), and substance P (SP)\/neurokinin (NK) family of receptors as targets, which have received the most attention and show the most promise in applying peptide receptor imaging\/theranostics to CNS tumors. We also discuss the specific problems that the CNS presents in applying this approach to CNS tumors because of the blood\u2013brain barrier in addition to the progress made. Clinical Trial Registry: NCT01578239 (NETTER\u20101)(NET), NCT03972488 (NETTER\u20102)(NET): VISION Trial (NCT03511664)[Lu\u2010177\u2010PSMA\u2010617] (Pluvicto) in advanced prostate cancer.<\/jats:p>","DOI":"10.1111\/jne.70287","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:56:32Z","timestamp":1791525392000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuropeptides and their receptors in\n                    <scp>CNS<\/scp>\n                    cancer imaging\/theranostics: Review of recent advances and increased interest with emphasis on the somatostatin\/bombesin\/substance P peptide receptor families"],"prefix":"10.1111","volume":"38","author":[{"given":"Terry W.","family":"Moody","sequence":"first","affiliation":[{"name":"Center for Cancer Training National Cancer Institute, National Institutes of Health  Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ramos\u2010Alvarez","sequence":"additional","affiliation":[{"name":"Digestive Disease Branch National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health  Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0095-4600","authenticated-orcid":false,"given":"Robert T.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Digestive Disease Branch National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health  Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13469"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2025.10.001"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2553"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1572118"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2019.11.005"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0078"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2015.09.009"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2025.05.005"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157396"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae191"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.728088"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae162"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122925"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae125"},{"issue":"4","key":"e_1_2_10_16_1","article-title":"An update on DOTA\u2010peptides PET imaging and potential advancements of radioligand therapy in intracranial meningiomas","volume":"15","author":"Benfante V","year":"2025","journal-title":"Life (Basel)"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2016.1164694"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0007"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnume.2025.1655419"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-1-199607010-00005"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70744"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2875"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00772"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17121905"},{"issue":"1","key":"e_1_2_10_27_1","article-title":"Treatment with radionuclide\u2010labeled peptides in refractory meningiomas: updated review and clinical perspectives","volume":"45","author":"Casas EA","year":"2026","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14090872"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2016.01.009"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000005980"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092364"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae192"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2013.1599"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c07850"},{"issue":"3","key":"e_1_2_10_35_1","first-page":"99","article-title":"Substance P and its receptors\u2014a potential target for novel medicines in malignant brain tumour therapies (mini\u2010review)","volume":"45","author":"Lazarczyk M","year":"2007","journal-title":"Folia Neuropathol"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa200"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.0119"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0063-6"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae082"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-63-2-433"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-199509000-00006"},{"issue":"21","key":"e_1_2_10_43_1","first-page":"5758","article-title":"Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system","volume":"47","author":"Reubi JC","year":"1987","journal-title":"Cancer Res"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.996489"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2826.2002.00801.x"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-018-3575-z"},{"key":"e_1_2_10_47_1","article-title":"Evaluating the functional status of somatostatin receptors by (99m)Tc\u2010octreotide scan in patients suffering from primary brain tumors","author":"Aghaee A","year":"2025","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050269"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2155-3"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000002377"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12632"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13467-9"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.122.263949"},{"issue":"11","key":"e_1_2_10_54_1","first-page":"1538","article-title":"Somatostatin receptor\u2010targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga\u2010DOTATATE\/\u2010TOC uptake","volume":"18","author":"Seystahl K","year":"2016","journal-title":"Neuro Oncol"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.23-44"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.191932"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-015-0106-2"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2025.14945"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000003341"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002021"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/02841860600833152"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001356"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41824-021-00104-3"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.191916"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1159\/000201083"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318293f051"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4NR01056F"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269633"},{"issue":"12","key":"e_1_2_10_69_1","first-page":"1911","article-title":"Intraarterial administration of peptide receptor radionuclide therapy in patients with advanced meningioma: initial safety and efficacy","volume":"65","author":"Amerein A","year":"2024","journal-title":"J Nucl Med"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1115-z"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.23736\/S1824-4785.24.03571-4"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266817"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-025-05266-9"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07336-6"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2533"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.147256"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-06044-9"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.249607"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17122039"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1200-0989"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.4103\/NI.Neurol-India-D-23-00252"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000005845"},{"issue":"5","key":"e_1_2_10_83_1","first-page":"1025","article-title":"Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y\u2010labeled DOTA0\u2010D\u2010Phe1\u2010Tyr3\u2010octreotide (DOTATOC): a pilot study in human gliomas","volume":"5","author":"Merlo A","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-001-0717-x"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.1053\/snuc.2002.31565"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2011.09.004"},{"key":"e_1_2_10_87_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.072819"},{"key":"e_1_2_10_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04966-w"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115701"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4015-2"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1085245"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000720"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18111608"},{"key":"e_1_2_10_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012369442-3\/50064-7"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(97)00080-4"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.107.07108"},{"key":"e_1_2_10_97_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711861105"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200205000-00003"},{"key":"e_1_2_10_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2010.02.014"},{"key":"e_1_2_10_100_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2024.01.004"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-024-01978-6"},{"key":"e_1_2_10_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<658::AID-IJC24>3.0.CO;2-P"},{"key":"e_1_2_10_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpet.2024.03.004"},{"key":"e_1_2_10_104_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1759-4189"},{"key":"e_1_2_10_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-017-1151-1"},{"key":"e_1_2_10_106_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720111793663624"},{"key":"e_1_2_10_107_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-024-00658-y"},{"key":"e_1_2_10_108_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2025.01.001"},{"key":"e_1_2_10_109_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.269444"},{"key":"e_1_2_10_110_1","first-page":"124","article-title":"Insights into bombesin receptors and ligands: highlighting recent advances","volume":"15","author":"Ramos\u2010Alvarez I","year":"2015","journal-title":"Peptides"},{"key":"e_1_2_10_111_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.91554"},{"key":"e_1_2_10_112_1","first-page":"235","article-title":"Human glioblastoma cell lines have neuropeptide receptors for bombesin\/gastrin\u2010releasing peptide","volume":"1","author":"Moody TW","year":"1989","journal-title":"J Mol Neurosci"},{"key":"e_1_2_10_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2025.109041"},{"key":"e_1_2_10_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-011-0508-0"},{"key":"e_1_2_10_115_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000006195"},{"key":"e_1_2_10_116_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612811319180015"},{"key":"e_1_2_10_117_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics5020119"},{"key":"e_1_2_10_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)13654-7"},{"key":"e_1_2_10_119_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.094375"},{"key":"e_1_2_10_120_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15212737"},{"key":"e_1_2_10_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2009.05.007"},{"key":"e_1_2_10_122_1","first-page":"G468","article-title":"Potent bombesin receptor antagonists distinguish receptor subtypes","volume":"259","author":"Schrenck T","year":"1990","journal-title":"Am J Physiol"},{"key":"e_1_2_10_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)55454-5"},{"key":"e_1_2_10_124_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104566200"},{"key":"e_1_2_10_125_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3011.1999.00028.x"},{"key":"e_1_2_10_126_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.045054"},{"key":"e_1_2_10_127_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno\/v01p0220"},{"key":"e_1_2_10_128_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.176636"},{"key":"e_1_2_10_129_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000005651"},{"key":"e_1_2_10_130_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-025-01198-7"},{"key":"e_1_2_10_131_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04392-7"},{"key":"e_1_2_10_132_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae078"},{"key":"e_1_2_10_133_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.165316"},{"key":"e_1_2_10_134_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e318203bb24"},{"issue":"3","key":"e_1_2_10_135_1","first-page":"149","article-title":"Differentiation between malignant transformation and tumour recurrence by (68)Ga\u2010bombesin and (18)F\u2010FDG\u2010PET, in patients with low grade gliomas","volume":"11","author":"Seiz M","year":"2008","journal-title":"Hell J Nucl Med"},{"key":"e_1_2_10_136_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00066"},{"key":"e_1_2_10_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10182"},{"key":"e_1_2_10_138_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.25599"},{"key":"e_1_2_10_139_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0TB03010D"},{"key":"e_1_2_10_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2013.12.027"},{"key":"e_1_2_10_141_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910610608"},{"key":"e_1_2_10_142_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574889809666141111142740"},{"key":"e_1_2_10_143_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2013.1588"},{"key":"e_1_2_10_144_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71148"},{"key":"e_1_2_10_145_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210113165805"},{"key":"e_1_2_10_146_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690039"},{"key":"e_1_2_10_147_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2820"},{"key":"e_1_2_10_148_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-024-01490-0"},{"key":"e_1_2_10_149_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.8b00063"},{"key":"e_1_2_10_150_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23102542"},{"key":"e_1_2_10_151_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11090443"},{"key":"e_1_2_10_152_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0153-5"},{"key":"e_1_2_10_153_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2019.11.004"},{"key":"e_1_2_10_154_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4225-7"},{"key":"e_1_2_10_155_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05350-y"},{"key":"e_1_2_10_156_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1385-5"},{"key":"e_1_2_10_157_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5358545"},{"key":"e_1_2_10_158_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-025-05167-x"},{"key":"e_1_2_10_159_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-14-26"},{"key":"e_1_2_10_160_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05433-w"},{"key":"e_1_2_10_161_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07338-4"},{"key":"e_1_2_10_162_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216208"},{"key":"e_1_2_10_163_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2BM00420H"},{"key":"e_1_2_10_164_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874471012666191017093721"},{"key":"e_1_2_10_165_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07540-4"},{"key":"e_1_2_10_166_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84036-5"},{"key":"e_1_2_10_167_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002806"},{"key":"e_1_2_10_168_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaa109"},{"key":"e_1_2_10_169_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004903"},{"key":"e_1_2_10_170_1","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.24-64"},{"key":"e_1_2_10_171_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071665"},{"key":"e_1_2_10_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109199"},{"key":"e_1_2_10_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2025.109056"},{"key":"e_1_2_10_174_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000003142"},{"key":"e_1_2_10_175_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000005904"},{"key":"e_1_2_10_176_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264850"},{"key":"e_1_2_10_177_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004612"},{"key":"e_1_2_10_178_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.980058"},{"issue":"3","key":"e_1_2_10_179_1","first-page":"e147","article-title":"Safety and feasibility of [177Lu] Lu\u2010PSMA therapy in glioblastoma","volume":"51","author":"Ghaedian T","year":"2026","journal-title":"Clin Nucl Med"},{"key":"e_1_2_10_180_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-026-07777-7"},{"key":"e_1_2_10_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2024.11.064"},{"key":"e_1_2_10_182_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000002049"},{"key":"e_1_2_10_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111694"},{"key":"e_1_2_10_184_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.5c00041"},{"key":"e_1_2_10_185_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161703"},{"key":"e_1_2_10_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2024.108961"},{"key":"e_1_2_10_187_1","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000003542"},{"key":"e_1_2_10_188_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1990.tb13004.x"},{"key":"e_1_2_10_189_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600235"},{"issue":"1","key":"e_1_2_10_190_1","first-page":"169","article-title":"Inhibition of experimental U\u2010118MG glioblastoma by targeted cytotoxic analogs of bombesin and somatostatin is associated with a suppression of angiogenic and antiapoptotic mechanisms","volume":"27","author":"Kanashiro CA","year":"2005","journal-title":"Int J Oncol"},{"issue":"2","key":"e_1_2_10_191_1","first-page":"709","article-title":"Regression of U\u201087 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN\u2010238","volume":"6","author":"Kiaris H","year":"2000","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129401"},{"key":"e_1_2_10_193_1","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ade222"},{"key":"e_1_2_10_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.105567"},{"key":"e_1_2_10_195_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M401938200"},{"key":"e_1_2_10_196_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2017.08.003"},{"key":"e_1_2_10_197_1","first-page":"491","article-title":"Targeted chemotherapy using a cytotoxic somatostatin conjugate to inhibit tumor growth and metastasis in nude mice","volume":"2","author":"Sun LC","year":"2008","journal-title":"Clin Med Oncol"},{"key":"e_1_2_10_198_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.104141"},{"key":"e_1_2_10_199_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612053507594"},{"issue":"2","key":"e_1_2_10_200_1","first-page":"290","article-title":"Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin\u2010related fusion protein DAB389 GRP","volume":"57","author":"JC vS","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_10_201_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2007.07.017"},{"key":"e_1_2_10_202_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.18879"},{"key":"e_1_2_10_203_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.11.011"},{"issue":"1","key":"e_1_2_10_204_1","first-page":"67S","article-title":"Candidates for peptide receptor radiotherapy today and in the future","volume":"46","author":"Reubi JC","year":"2005","journal-title":"J Nucl Med"},{"key":"e_1_2_10_205_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27994-2_34"},{"key":"e_1_2_10_206_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202500676"},{"issue":"10","key":"e_1_2_10_207_1","first-page":"1825","article-title":"Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging","volume":"36","author":"Reubi JC","year":"1995","journal-title":"J Nucl Med"},{"key":"e_1_2_10_208_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00145-1"},{"key":"e_1_2_10_209_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666151221150733"},{"key":"e_1_2_10_210_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00523"},{"key":"e_1_2_10_211_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.21254"},{"key":"e_1_2_10_212_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164162"},{"key":"e_1_2_10_213_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16020341"},{"key":"e_1_2_10_214_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16060810"},{"key":"e_1_2_10_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2010.06.023"},{"key":"e_1_2_10_216_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225766"},{"key":"e_1_2_10_217_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3490"},{"key":"e_1_2_10_218_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.263971"},{"key":"e_1_2_10_219_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06364-4"},{"key":"e_1_2_10_220_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270411"},{"key":"e_1_2_10_221_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-024-01164-9"},{"key":"e_1_2_10_222_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091326"}],"container-title":["Journal of Neuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jne.70287","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jne.70287","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jne.70287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:57:00Z","timestamp":1792976220000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jne.70287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":221,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/jne.70287"],"URL":"https:\/\/doi.org\/10.1111\/jne.70287","archive":["Portico"],"relation":{},"ISSN":["0953-8194","1365-2826"],"issn-type":[{"value":"0953-8194","type":"print"},{"value":"1365-2826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"2026-02-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70287"}}